Zenotech Laboratories Ltd

NSE: ZENOTECH · BSE: 532039 · Pharmaceuticals & Biotechnology · 11 announcements

Share price: ₹41.71
Market cap: ₹254.6 Cr
Revenue (annual): ₹43.61 Cr
Net profit (annual): ₹-1.07 Cr
P/E (TTM): -101.1×Sector 47.3×
Promoter holding: 68.84%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 4 Other Announcement 2 Annual General Meeting 2 Price Movement Clarification 1 Debt & Borrowing 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

4 announcements with these filters

28 Jul 2026 14:41 IST BSE

Financial Results

Zenotech Laboratories Q1 FY27 Results: Net Loss of ₹0.5 Cr

Zenotech Laboratories Ltd reported revenue from operations of ₹9.6 Cr (+11.6% YoY) and a net loss of ₹0.5 Cr for Q1 FY27.

Key figure: Net loss ₹0.5 Cr

Open full results → Read the filing ↗

29 Apr 2026 16:12 IST BSE

Financial Results

Zenotech Laboratories Q4 FY26 Results: Net Loss of ₹3.2 Cr

Zenotech Laboratories Ltd reported revenue from operations of ₹8.9 Cr (-19.8% YoY) and a net loss of ₹3.2 Cr for Q4 FY26.

Key figure: Net loss ₹3.2 Cr

Open full results → Read the filing ↗

29 Apr 2026 16:12 IST BSE

Financial Results

Zenotech Laboratories Financial Results

Zenotech Laboratories Ltd approved audited standalone financial results for the quarter and year ended March 31, 2026. The Board met on April 29, 2026, to review performance and the auditor's report. These results were prepared in accordance with Ind AS and Regulation 33 of SEBI Listing Regulations.

Read the filing ↗

13 Apr 2026 13:12 IST BSE

Financial Results

Zenotech Laboratories Q3 FY26 Results: Net Profit ₹1.9 Cr, Up 11.8% YoY

Zenotech Laboratories Ltd reported net profit of ₹1.9 Cr (+11.8% YoY) for Q3 FY26.

Key figure: Net profit ₹1.9 Cr · +11.8% YoY

Open full results → Read the filing ↗